All Stories

  1. AhR and IDO1 in pathogenesis of Covid-19 and the “Systemic AhR Activation Syndrome:” a translational review and therapeutic perspectives

    Article • Restorative Neurology and Neuroscience, September 2020, IOS Press

    Waldemar Turski

  2. The Influence of Palmatine Isolated from Berberis sibirica Radix on Pentylenetetrazole-Induced Seizures in Zebrafish

    Article • Cells, May 2020, MDPI AG

    Waldemar Turski

  3. Phenotypic Characterization of Larval Zebrafish (Danio rerio) with Partial Knockdown of the cacna1a Gene

    Article • Molecular Neurobiology, December 2019, Springer Science + Business Media

    Waldemar Turski

  4. Kynurenic acid and cancer: facts and controversies

    Article • Cellular and Molecular Life Sciences, October 2019, Springer Science + Business Media

    Waldemar Turski

  5. Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy

    Article • Seizure, July 2019, Elsevier

    Waldemar Turski

  6. Quinaldic acid induces changes in the expression of p53 tumor suppressor both on protein and gene level in colon cancer LS180 cells

    Article • Pharmacological Reports, April 2019, Springer Science + Business Media

    Waldemar Turski

  7. The presence and distribution of G protein-coupled receptor 35 (GPR35) in the human cornea – Evidences from in silico gene expression analysis and immunodetection

    Article • Experimental Eye Research, February 2019, Elsevier

    Waldemar Turski

  8. Fate and distribution of kynurenic acid administered as beverage

    Article • Pharmacological Reports, December 2018, Springer Science + Business Media

    Waldemar Turski

  9. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, October 2018, Springer Science + Business Media

    Waldemar Turski

  10. Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats

    Article • Analytical Cellular Pathology, September 2018, Hindawi Publishing Corporation

    Waldemar Turski

  11. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro

    Article • Neurotoxicity Research, September 2018, Springer Science + Business Media

    Waldemar Turski

  12. Tryptophan, kynurenine, kynurenic acid concentrations and indoleamine 2,3-dioxygenase activity in serum and milk of dairy cows with subclinical mastitis caused by coagulase-negative staphylococci

    Article • Reproduction in Domestic Animals, August 2018, Wiley

    Waldemar Turski

  13. Effect of Kynurenic Acid on Pupae Viability of Drosophila melanogaster cinnabar and cardinal Eye Color Mutants with Altered Tryptophan-Kynurenine Metabolism

    Article • Neurotoxicity Research, April 2018, Springer Science + Business Media

    Waldemar Turski

  14. Quinaldic acid in synovial fluid of patients with rheumatoid arthritis and osteoarthritis and its effect on synoviocytes in vitro

    Article • Pharmacological Reports, April 2018, Springer Science + Business Media

    Waldemar Turski

  15. Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye

    Article • Current Medicinal Chemistry, October 2017, Bentham Science Publishers

    Waldemar Turski

  16. Effects of tryptophan, kynurenine and kynurenic acid exerted on human reconstructed corneal epithelium in vitro

    Article • Pharmacological Reports, August 2017, Springer Science + Business Media

    Waldemar Turski

  17. Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications

    Article • Neurotoxicity Research, July 2017, Springer Science + Business Media

    Waldemar Turski

  18. The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro

    Article • Pharmacological Reports, June 2017, Springer Science + Business Media

    Waldemar Turski

  19. Influence of picolinic acid on seizure susceptibility in mice

    Article • Pharmacological Reports, February 2017, Springer Science + Business Media

    Waldemar Turski

  20. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro

    Article • European Journal of Pharmacology, October 2016, Elsevier

    Waldemar Turski

  21. Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms

    Article • Neurochemical Research, July 2016, Springer Science + Business Media

    Waldemar Turski

  22. Protective action of nicotinic acid benzylamide in a variety of chemically-induced seizures in mice

    Article • Pharmacological Reports, April 2016, Springer Science + Business Media

    Waldemar Turski

  23. The effect of kynurenic acid on the synthesis of selected cytokines by murine splenocytes – in vitro and ex vivo studies

    Article • Central European Journal of Immunology, January 2016, Termedia Sp. z.o.o.

    Joanna Małaczewska, Waldemar Turski

  24. Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord

    Article • PLoS ONE, November 2015, PLOS

    Waldemar Turski

  25. Cholinesterase activity in blood and pesticide presence in sweat as biomarkers of children`s environmental exposure to crop protection chemicals

    Article • Annals of Agricultural and Environmental Medicine, September 2015, Institute of Rural Health

    Waldemar Turski

  26. Trace metal analyses in honey samples from selected countries. A potential use in bio-monitoring

    Article • International Journal of Environmental & Analytical Chemistry, July 2015, Taylor & Francis

    Włodzimierz Opoka, Waldemar Turski

  27. Quinaldic acid inhibits proliferation of colon cancer HT-29 cells in vitro: Effects on signaling pathways

    Article • European Journal of Pharmacology, June 2015, Elsevier

    Waldemar Turski

  28. Serum tryptophan and its metabolites in female dogs undergoing ovariohysterectomy as treatment of pyometra or as elective spay surgery

    Article • Theriogenology, May 2015, Elsevier

    Waldemar Turski

  29. Kynurenic Acid Content in Selected Culinary Herbs and Spices

    Article • Journal of Chemistry, January 2015, Hindawi Publishing Corporation

    Waldemar Turski

  30. On the toxicity of kynurenic acid in vivo and in vitro

    Article • Pharmacological Reports, December 2014, Elsevier

    Joanna Małaczewska, Waldemar Turski

  31. Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats

    Article • European Journal of Pharmacology, November 2014, Elsevier

    Waldemar Turski

  32. Kynurenic acid inhibits colon cancer proliferation in vitro: effects on signaling pathways

    Article • Amino Acids, July 2014, Springer Science + Business Media

    Waldemar Turski

  33. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure

    Article • Pharmacological Reports, June 2014, Springer Science + Business Media

    Waldemar Turski

  34. Orphenadrine-induced convulsive status epilepticus in rats responds to the NMDA antagonist dizocilpine

    Article • Pharmacological Reports, June 2014, Springer Science + Business Media

    Waldemar Turski

  35. Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells

    Article • Pharmacological Reports, February 2014, Springer Science + Business Media

    Waldemar Turski

  36. Effect of oral administration of kynurenic acid on the activity of the peripheral blood leukocytes in mice

    Article • Central European Journal of Immunology, January 2014, Termedia Sp. z.o.o.

    Joanna Małaczewska, Waldemar Turski

  37. Presence and distribution of l-kynurenine aminotransferases immunoreactivity in human cataractous lenses

    Article • Acta Ophthalmologica, April 2013, Wiley

    Waldemar Turski

  38. Effect of dietary administration of kynurenic acid on the activity of splenocytes of the rainbow trout (Oncorhynchus mykiss)

    Article • Central European Journal of Immunology, January 2013, Termedia Sp. z.o.o.

    Joanna Małaczewska, Waldemar Turski

  39. Tryptophan-Kynurenine Metabolism and Insulin Resistance in Hepatitis C Patients

    Article • Hepatitis Research and Treatment, January 2013, Hindawi Publishing Corporation

    Waldemar Turski

  40. Kynurenic acid – a new tool in the treatment of hiperhomocysteinemia and its consequences?

    Article • Postępy Higieny i Medycyny Doświadczalnej, June 2012, Index Copernicus

    Waldemar Turski

  41. Potato- An Important Source of Nutritional Kynurenic Acid

    Article • Plant Foods for Human Nutrition, March 2012, Springer Science + Business Media

    Waldemar Turski

  42. Kynurenic acid in human renal cell carcinoma: its antiproliferative and antimigrative action on Caki-2 cells

    Article • Amino Acids, February 2012, Springer Science + Business Media

    Waldemar Turski

  43. Main dietary compounds and pancreatic cancer risk. The quantitative analysis of case–control and cohort studies

    Article • Cancer Epidemiology, February 2012, Elsevier

    Waldemar Turski

  44. Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats

    Article • Acta Neurovegetativa, December 2011, Springer Science + Business Media

    Waldemar Turski

  45. Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells

    Article • Scandinavian Journal of Gastroenterology, May 2011, Taylor & Francis

    Waldemar Turski

  46. Orphenadrine induces secondarily generalized convulsive status epilepticus in rats

    Article • Brain Research Bulletin, April 2011, Elsevier

    Waldemar Turski

  47. Distribution, Synthesis, and Absorption of Kynurenic Acid in Plants

    Article • Planta Medica, December 2010, Thieme Publishing Group

    Waldemar Turski

  48. Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat—possible involvement of kynurenic acid

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, June 2010, Springer Science + Business Media

    Waldemar Turski

  49. Evidences for pharmacokinetic interaction of riluzole and topiramate with pilocarpine in pilocarpine-induced seizures in rats

    Article • Epilepsy Research, February 2010, Elsevier

    Waldemar Turski

  50. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients

    Article • Leukemia Research, January 2010, Elsevier

    Waldemar Turski

  51. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain — In vitro and ex vivo evidence

    Article • Toxicology and Applied Pharmacology, October 2009, Elsevier

    Waldemar Turski

  52. High concentration of kynurenic acid in bile and pancreatic juice

    Article • Amino Acids, October 2008, Springer Science + Business Media

    Tomasz Saran, Waldemar Turski

  53. Sedative and anticonvulsant drugs suppress postnatal neurogenesis

    Article • Annals of Neurology, October 2008, Wiley

    Waldemar Turski

  54. Anticonvulsant and acute adverse effect profiles of picolinic acid 2-fluoro-benzylamide in various experimental seizure models and chimney test in mice

    Article • Fundamental and Clinical Pharmacology, February 2008, Wiley

    Waldemar Turski

  55. Micromolar concentration of kynurenic acid in rat small intestine

    Article • Amino Acids, January 2008, Springer Science + Business Media

    Waldemar Turski

  56. Presence of kynurenic acid in food and honeybee products

    Article • Amino Acids, January 2008, Springer Science + Business Media

    Waldemar Turski

  57. Characterization of the anticonvulsant profile of isonicotinic acid benzylamide in various experimental seizure models in mice

    Article • Neuroscience Letters, June 2007, Elsevier

    Waldemar Turski

  58. Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis

    Article • Acta Neurovegetativa, March 2007, Springer Science + Business Media

    Mr axel petzold, Waldemar Turski

  59. NMDA antagonists exert distinct effects in experimental organophosphate or carbamate poisoning in mice

    Article • Toxicology and Applied Pharmacology, March 2007, Elsevier

    Waldemar Turski

  60. Lithium–methomyl induced seizures in rats: A new model of status epilepticus?

    Article • Toxicology and Applied Pharmacology, March 2007, Elsevier

    Waldemar Turski

  61. Elevated Concentrations of Kynurenic Acid, a Tryptophan Derivative, in Dense Nuclear Cataracts

    Article • Current Eye Research, January 2007, Taylor & Francis

    Waldemar Turski

  62. Ammonia at pathophysiologically relevant concentrations activates kynurenic acid synthesis in cultured astrocytes and neurons

    Article • NeuroToxicology, July 2006, Elsevier

    Waldemar Turski

  63. Enhancement of brain kynurenic acid production by anticonvulsants—Novel mechanism of antiepileptic activity?

    Article • European Journal of Pharmacology, July 2006, Elsevier

    Waldemar Turski

  64. Effect of glutamate receptor antagonists and antirheumatic drugs on proliferation of synoviocytes in vitro

    Article • European Journal of Pharmacology, March 2006, Elsevier

    Waldemar Turski

  65. Kynurenic acid synthesis in bovine retinal slices – effect of glutamate agonists

    Article • Acta Neurovegetativa, February 2006, Springer Science + Business Media

    Waldemar Turski

  66. Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro

    Article • Rheumatology International, October 2005, Springer Science + Business Media

    Waldemar Turski

  67. Demonstration of Kynurenine Aminotransferases I and II and Characterization of Kynurenic Acid Synthesis in Oligodendrocyte Cell Line (OLN-93)

    Article • Neurochemical Research, August 2005, Springer Science + Business Media

    Waldemar Turski

  68. Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons

    Article • Journal of Neuroscience Research, June 2005, Wiley

    Waldemar Turski

  69. Dual effect ofDL-homocysteine andS-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid

    Article • Journal of Neuroscience Research, February 2005, Wiley

    Waldemar Turski

  70. Ethosuximide and valproate display high efficacy against lindane-induced seizures in mice

    Article • Toxicology Letters, December 2004, Elsevier

    Waldemar Turski

  71. Carbamazepine enhances brain production of kynurenic acid in vitro

    Article • European Journal of Pharmacology, September 2004, Elsevier

    Waldemar Turski

  72. Age-dependent decrease of retinal kynurenate and kynurenine aminotransferases in DBA/2J mice, a model of ocular hypertension

    Article • Vision Research, March 2004, Elsevier

    Waldemar Turski

  73. Kynurenic acid in ALS patients

    Article • Acta Neurologica Scandinavica, March 2004, Wiley

    Waldemar Turski

  74. Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, March 2004, Springer Science + Business Media

    Waldemar Turski

  75. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy

    Article • Journal of Neuroscience Research, January 2004, Wiley

    Tomasz Saran, Waldemar Turski

  76. Content of Kynurenic Acid and Activity of Kynurenine Aminotransferases in Mammalian Eyes

    Article • Ophthalmic Research, January 2004, Karger Publishers

    Waldemar Turski

  77. Expression of kynurenine aminotransferases in the rat retina during development

    Article • Vision Research, January 2004, Elsevier

    Waldemar Turski

  78. l-Cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II

    Article • Neuroscience Letters, July 2003, Elsevier

    Waldemar Turski

  79. Ontogenic changes of kynurenine aminotransferase I activity and its expression in the chicken retina

    Article • Vision Research, June 2003, Elsevier

    Waldemar Turski

  80. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis

    Article • Acta Neurologica Scandinavica, May 2003, Wiley

    Waldemar Turski

  81. Dizocilpine Improves Beneficial Effects of Cholinergic Antagonists in Anticholinesterase-Treated Mice

    Article • Toxicological Sciences, April 2003, Oxford University Press (OUP)

    Waldemar Turski

  82. Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage

    Article • Vision Research, March 2003, Elsevier

    Waldemar Turski

  83. Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients

    Article • Neuroscience Letters, October 2002, Elsevier

    Waldemar Turski

  84. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats

    Article • Neuroscience Letters, September 2002, Elsevier

    Waldemar Turski

  85. Regulation of kynurenic acid synthesis in C6 glioma cells

    Article • Journal of Neuroscience Research, May 2002, Wiley

    Waldemar Turski

  86. AMPA and GABAB receptor antagonists and their interaction in rats with a genetic form of absence epilepsy

    Article • European Journal of Pharmacology, November 2001, Elsevier

    Waldemar Turski

  87. Amlodipine enhances the activity of antiepileptic drugs against pentylenetetrazole-induced seizures

    Article • Pharmacology Biochemistry and Behavior, April 2001, Elsevier

    Waldemar Turski

  88. Kynurenine Aminotransferase I Activity in Human Placenta

    Article • Placenta, February 2001, Elsevier

    Waldemar Turski

  89. On the interactions between antimuscarinic atropine and NMDA receptor antagonists in anticholinesterase-treated mice

    Article • Archives of Toxicology, January 2001, Springer Science + Business Media

    Waldemar Turski

  90. Amino Acid Derivatives with Anticonvulsant Activity.

    Article • Chemical and Pharmaceutical Bulletin, January 2001, Pharmaceutical Society of Japan

    Waldemar Turski

  91. Evidence for Intraocular Synthesis of Kynurenic Acid, a Putative Endogenous Neuroprotectant

    Article • Ophthalmic Research, January 2001, Karger Publishers

    Waldemar Turski

  92. Formation of endogenous glutamatergic receptors antagonist kynurenic acid — differences between cortical and spinal cord slices

    Article • Brain Research, September 2000, Elsevier

    Waldemar Turski

  93. Proconvulsive effects of the mitochondrial respiratory chain inhibitor — 3-nitropropionic acid

    Article • European Journal of Pharmacology, September 2000, Elsevier

    Waldemar Turski

  94. NMDA- But Not Kainate-Mediated Events Reduce Efficacy of Some Antiepileptic Drugs Against Generalized Tonic-Clonic Seizures in Mice

    Article • Epilepsia, November 1999, Wiley

    Waldemar Turski

  95. AMPA/kainate-related mechanisms contribute to convulsant and proconvulsant effects of 3-nitropropionic acid

    Article • European Journal of Pharmacology, April 1999, Elsevier

    Tomasz Saran, Waldemar Turski

  96. Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice

    Article • European Journal of Pharmacology, October 1998, Elsevier

    Tomasz Saran, Waldemar Turski

  97. A potential anti-asthmatic drug, CR 2039, enhances the anticonvulsive activity of some antiepileptic drugs against pentetrazol in mice

    Article • European Neuropsychopharmacology, August 1998, Elsevier

    Waldemar Turski

  98. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice

    Article • European Journal of Pharmacology, July 1998, Elsevier

    Waldemar Turski

  99. EFFECT OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS ON THE ANTICONVULSIVE ACTIVITY OF VALPROATE AND DIPHENYLHYDANTOIN AGAINST MAXIMAL ELECTROSHOCK-INDUCED SEIZURES IN MICE

    Article • Pharmacological Research, May 1998, Elsevier

    Waldemar Turski

  100. Acute ammonia treatment in vitro and in vivo inhibits the synthesis of a neuroprotectant kynurenic acid in rat cerebral cortical slices

    Article • Brain Research, March 1998, Elsevier

    Tomasz Saran, Waldemar Turski

  101. Chlormethiazole anticonvulsive efficacy diminished by N-methyl-d-aspartate but not kainate in mice

    Article • European Journal of Pharmacology, March 1998, Elsevier

    Waldemar Turski

  102. Interaction of Calcium Channel Blockers and Excitatory Amino Acid Antagonists with Conventional Antiepileptic Drugs

    Article • CNS Drug Reviews, December 1996, Wiley

    Waldemar Turski

  103. Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs

    Article • Metabolic Brain Disease, June 1996, Springer Science + Business Media

    Waldemar Turski

  104. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice

    Article • European Journal of Pharmacology, August 1995, Elsevier

    Waldemar Turski

  105. Influence of a Ca2+ channel agonist, BAY k-8644, on the anticonvulsant activity of NMDA and non-NMDA receptor antagonists

    Article • European Journal of Pharmacology, October 1994, Elsevier

    Waldemar Turski

  106. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice

    Article • Neuropharmacology, May 1994, Elsevier

    Waldemar Turski

  107. The NMDA antagonist procyclidine, but not ifenprodil, enhances the protective efficacy of common antiepileptics against maximal electroshock-induced seizures in mice

    Article • Acta Neurovegetativa, February 1994, Springer Science + Business Media

    Waldemar Turski

  108. Towards an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology

    Article • Cellular and Molecular Life Sciences, December 1993, Springer Science + Business Media

    Waldemar Turski

  109. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics

    Article • European Journal of Pharmacology, November 1993, Elsevier

    Waldemar Turski

  110. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice

    Article • Neuropharmacology, September 1993, Elsevier

    Waldemar Turski

  111. Competitive antagonist of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in mice

    Article • European Journal of Pharmacology, February 1993, Elsevier

    Waldemar Turski

  112. Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures

    Article • Neuropharmacology, October 1992, Elsevier

    Waldemar Turski

  113. Age-related changes in kynurenic acid production in rat brain

    Article • Brain Research, August 1992, Elsevier

    Waldemar Turski

  114. Age dependency of the susceptibility of rats to aminooxyacetic acid seizures

    Article • Developmental Brain Research, June 1992, Elsevier

    Waldemar Turski

  115. NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil

    Article • Cognitive Brain Research, June 1992, Elsevier

    Waldemar Turski

  116. Kynurenic Acid: A Potential Pathogen in Brain Disorders

    Article • Annals of the New York Academy of Sciences, May 1992, Wiley

    Waldemar Turski

  117. Long-Term Effects of Pilocarpine in Rats: Structural Damage of the Brain Triggers Kindling and Spontaneous I Recurrent Seizures

    Article • Epilepsia, December 1991, Wiley

    Waldemar Turski

  118. Aminooxyacetic acid produces excitotoxic lesions in the rat striatum

    Article • Synapse, October 1991, Wiley

    Waldemar Turski

  119. Influence of MK-801 on the anticonvulsant activity of antiepileptics

    Article • European Journal of Pharmacology, August 1991, Elsevier

    Waldemar Turski

  120. Systemic kainic acid administration in rats: Effects on kynurenic acid production in vitro and in vivo

    Article • Experimental Neurology, July 1991, Elsevier

    Waldemar Turski

  121. Seizures induced by aminooxyacetic acid in mice: Pharmacolgical characteristics

    Article • Synapse, March 1991, Wiley

    Waldemar Turski

  122. Paradoxical anticonvulsant acitivity of the ?hyphen;Aminobutyrate antagonist bicuculline methiodide in the rat striatum

    Article • Synapse, January 1991, Wiley

    Waldemar Turski

  123. Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks

    Article • Neuropharmacology, December 1990, Elsevier

    Waldemar Turski

  124. Substantia nigra: A site of action of muscle relaxant drugs

    Article • Annals of Neurology, September 1990, Wiley

    Waldemar Turski

  125. Determination of extracellular kynurenic acid in the striatum of unanesthetized rats: Effect of aminooxyacetic acid

    Article • Neuroscience Letters, August 1990, Elsevier

    Waldemar Turski

  126. Excitatory amino acid antagonists protect mice against seizures induced by bicuculline

    Article • Brain Research, April 1990, Elsevier

    Waldemar Turski

  127. Blockade of excitatory neurotransmission in the globus pallidus induces rigidity and akinesia in the rat: implications for excitatory neurotransmission in pathogenesis of Parkinson's diseases

    Article • Brain Research, March 1990, Elsevier

    Waldemar Turski

  128. The entopeduncular nucleus regulates muscle tone in genetically spastic rats: role of substance P and γ-aminobutyric acid

    Article • Brain Research, February 1990, Elsevier

    Waldemar Turski

  129. Dopamine control of seizure propagation: Intranigral dopamine D1 agonist SKF-38393 enhances susceptibility of seizures

    Article • Synapse, January 1990, Wiley

    Waldemar Turski

  130. Rat Brain Slices Produce and Liberate Kynurenic Acid upon Exposure to l-Kynurenine

    Article • Journal of Neurochemistry, May 1989, Wiley

    Waldemar Turski

  131. Homocysteic acid: convulsant action of stereoisomers in mice

    Article • Brain Research, February 1989, Elsevier

    Waldemar Turski

  132. Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy

    Article • Synapse, January 1989, Wiley

    Waldemar Turski

  133. Differential effects of non-steroidal anti-inflammatory drugs on seizures produced by pilocarpine in rats

    Article • Brain Research, October 1988, Elsevier

    Waldemar Turski

  134. Identification and quantification of kynurenic acid in human brain tissue

    Article • Brain Research, June 1988, Elsevier

    Waldemar Turski

  135. On the disposition of intrahippocampally injected kynurenic acid in the rat

    Article • Experimental Brain Research, January 1988, Springer Science + Business Media

    Waldemar Turski

  136. The susceptibility of rats to pilocarpine-induced seizures is age-dependent

    Article • Developmental Brain Research, December 1987, Elsevier

    Waldemar Turski

  137. Substantia nigra and motor control in the rat: effect of intranigral α-kainate and γ-d-glutamylaminomethylsulphonate on motility

    Article • Brain Research, October 1987, Elsevier

    Waldemar Turski

  138. Effect of Aminophylline and Enprofylline on the Protective Efficacy of Common Antiepileptic Drugs Against Electroconvulsions in Mice

    Article • Epilepsia, August 1987, Wiley

    Waldemar Turski

  139. Only certain antiepileptic drugs prevent seizures induced by pilocarpine

    Article • Brain Research Reviews, July 1987, Elsevier

    Waldemar Turski

  140. Effects ofl-cysteine-sulphinate andl-aspartate, mixed excitatory amino acid agonists, on the membrane potential of cat caudate neurons

    Article • Brain Research, June 1987, Elsevier

    Waldemar Turski

  141. Evidence that antagonism at non-NMDA receptors results in anticonvulsant action

    Article • European Journal of Pharmacology, April 1987, Elsevier

    Waldemar Turski

  142. Convulsant action of morphine, [d-ala2, d-leu5]-enkephalin and naloxone in the rat amygdala: Electroencephalographic, morphological and behavioural sequelae

    Article • Neuroscience, February 1987, Elsevier

    Waldemar Turski

  143. Seizures produced by pilocarpine: Neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain

    Article • Brain Research, November 1986, Elsevier

    Waldemar Turski

  144. Effect of Aminophylline on the Protective Action of Common Antiepileptic Drugs Against Electroconvulsions in Mice

    Article • Epilepsia, June 1986, Wiley

    Waldemar Turski

  145. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: Effects of intranigral 2-amino-7-phosphonoheptanoate and n-methyl-d-aspartate

    Article • Neuroscience, May 1986, Elsevier

    Waldemar Turski

  146. Susceptibility to seizures produced by pilocarpine in rats after microinjection of isonnazid or γ-vinyl-GABA into the substantia nigra

    Article • Brain Research, April 1986, Elsevier

    Professor Luiz E Mello, Waldemar Turski

  147. Aminophylline and CGS 8216 Reverse the Protective Action of Diazepam Against Electroconvulsions in Mice

    Article • Epilepsia, December 1985, Wiley

    Waldemar Turski

  148. Effects of aminophylline and 2-chloroadenosine on seizures produced by pilocarpine in rats: Morphological and electroencephalographic correlates

    Article • Brain Research, December 1985, Elsevier

    Waldemar Turski

  149. Modification of the anticonvulsant activity of 2-amino-5-phosphonovalerate by agents affecting different neurotransmitter systems

    Article • Neuropharmacology, October 1985, Elsevier

    Waldemar Turski

  150. Phosphonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in mice

    Article • Neuroscience Research, October 1985, Elsevier

    Waldemar Turski

  151. Muscle relaxant action of 2-chloroadenosine in genetically spastic rats is independent of γ-aminobutyric acid-mediated inhibition

    Article • Neuroscience Letters, March 1985, Elsevier

    Waldemar Turski

  152. Effects of morphine and naloxone on pilocarpine-induced convulsions in rats

    Article • Neuropeptides, February 1985, Elsevier

    Waldemar Turski

  153. Muscle relaxant action of excitatory amino acid antagonists

    Article • Neuroscience Letters, February 1985, Elsevier

    Waldemar Turski

  154. Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: An electroencephalographic, behavioural and morphological analysis

    Article • Neuroscience, January 1985, Elsevier

    Waldemar Turski

  155. Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis

    Article • Brain Research, November 1984, Elsevier

    Professor Luiz E Mello, Waldemar Turski

  156. Effect of aminophylline on muscle relaxant action of diazepam and phenobarbitone in genetically spastic rats: Further evidence for a purinergic mechanism in the action of diazepam

    Article • European Journal of Pharmacology, August 1984, Elsevier

    Waldemar Turski

  157. Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydanton in mice

    Article • European Journal of Pharmacology, May 1984, Elsevier

    Waldemar Turski

  158. A specific benzodiazepine antagonist CGS 8216 reverses the muscle relaxant effect of diazepam but not that of phenobarbitone

    Article • European Journal of Pharmacology, March 1984, Elsevier

    Waldemar Turski

  159. Differential effects of baclofen, ³-hydroxybutyric acid and muscimol on the protective action of phenobarbital and diphenylhydantoin against maximal electroshock-induced seizures in mice

    Article • Neuropharmacology, February 1984, Elsevier

    Waldemar Turski

  160. Studies on the Mechanism of Wet Dog Shakes Produced by Carbachol in Rats

    Article • Pharmacology, January 1984, Karger Publishers

    Waldemar Turski

  161. Cholinomimetics produce seizures and brain damage in rats

    Article • Cellular and Molecular Life Sciences, December 1983, Springer Science + Business Media

    Waldemar Turski

  162. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study

    Article • Behavioural Brain Research, September 1983, Elsevier

    Waldemar Turski

  163. Intrahippocampal bethanechol in rats: Behavioural, electroencephalographic and neuropathological correlates

    Article • Behavioural Brain Research, March 1983, Elsevier

    Waldemar Turski

  164. Does morphine withdrawal produce brain damage in rats?

    Article • Life Sciences, January 1983, Elsevier

    Waldemar Turski

  165. Intraamygdaloid morphine produces seizures and brain damage in rats

    Article • Life Sciences, January 1983, Elsevier

    Waldemar Turski

  166. Dyphenylhydantoin enhancement of diazepam effects on locomotor activity in mice

    Article • Psychopharmacology, February 1982, Springer Science + Business Media

    Waldemar Turski

  167. Effect of antidepressant drugs on carbachol chloride-induced wet dog shake behaviour in rats

    Article • Neuropharmacology, December 1981, Elsevier

    Waldemar Turski

  168. (RS)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid: Wet dog shakes, catalepsy and body temperature changes in rats

    Article • Pharmacology Biochemistry and Behavior, October 1981, Elsevier

    Waldemar Turski

  169. Effect of combined treatment of phenytoin with diazepam on the susceptibility of mice to electroconvulsions

    Article • Journal of Pharmacy and Pharmacology, September 1981, Wiley

    Waldemar Turski

  170. Effect of trazodone, mianserin, iprindole and zimelidine on wet dog shakes produced by carbachol in rats

    Article • Journal of Pharmacy and Pharmacology, September 1981, Wiley

    Waldemar Turski

  171. Effects of Some Antiepileptic Drugs in Pentetrazol-Induced Convulsions in Mice Lesioned with Kainic Acid

    Article • Epilepsia, August 1981, Wiley

    Waldemar Turski

  172. Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats

    Article • Psychopharmacology, May 1981, Springer Science + Business Media

    Waldemar Turski

  173. Effects of morphine and nalorphine on kainic acid-induced hypothermia in rats

    Article • Psychopharmacology, January 1981, Springer Science + Business Media

    Waldemar Turski

  174. Studies of carbachol-induced wet-dog shake behavior in rats

    Article • Psychopharmacology, January 1981, Springer Science + Business Media

    Waldemar Turski